Skip to main content
. 2019 Jan 12;20(2):294. doi: 10.3390/ijms20020294

Figure 9.

Figure 9

Conclusion of the current study. The current study demonstrates that ritonavir (RTV), an HAART drug, can cause oxidative stress and endothelial dysfunction by increase of ROS production and decrease of expression of SOD1, SOD2 and eNOS in human endothelial cells. Thus, RTV-induced oxidative stress and endothelial dysfunction could contribute to cardiovascular disease. On the other hand, ginsenoside Rb1 can effectively block the effects of RTV via a unique mechanism by which Rb1 specifically binds to and activates ER-β and induces upregulation of SOD1, SOD2 and eNOS in human endothelial cells. Rb1 can also directly scavenge ROS.